Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prelude Therapeutics Incorporated - Common Stock (NQ:PRLD)

1.390 -0.370 (-21.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,057,459
Open 1.650
Bid (Size) 1.360 (1,400)
Ask (Size) 1.380 (1,000)
Prev. Close 1.760
Today's Range 1.380 - 1.650
52wk Range 0.6101 - 4.220
Shares Outstanding 54,808,715
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
In today's session, these stocks are experiencing unusual volume.
Let's have a look at the stocks with an unusual volume in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga

Performance

YTD
+11.2%
+11.2%
1 Month
-4.8%
-4.8%
3 Month
+63.6%
+63.6%
6 Month
+81.9%
+81.9%
1 Year
+7.8%
+7.8%

More News

Read More
Which stocks are experiencing notable movement on Tuesday?
Via Chartmill
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
Tuesday's session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Dow Dips Over 400 Points; Pfizer Earnings Top Estimates
Via Benzinga
Topics Stocks
Tuesday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Prelude Therapeutics Announces Strategic Business Update
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
These stocks are moving in today's after hours session
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
Tuesday's session: top gainers and losers
Via Chartmill
Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
Prelude Cuts Q2 Losses and Costs 13%
Via The Motley Fool
Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
Prelude Therapeutics to Participate in Citizens Life Sciences Conference
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
Prelude Announces Presentations at 2025 AACR Annual Meeting
From Prelude Therapeutics, Incorporated
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session.
Via Chartmill

Frequently Asked Questions

Is Prelude Therapeutics Incorporated - Common Stock publicly traded?
Yes, Prelude Therapeutics Incorporated - Common Stock is publicly traded.
What exchange does Prelude Therapeutics Incorporated - Common Stock trade on?
Prelude Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Prelude Therapeutics Incorporated - Common Stock?
The ticker symbol for Prelude Therapeutics Incorporated - Common Stock is PRLD on the Nasdaq Stock Market
What is the current price of Prelude Therapeutics Incorporated - Common Stock?
The current price of Prelude Therapeutics Incorporated - Common Stock is 1.390
When was Prelude Therapeutics Incorporated - Common Stock last traded?
The last trade of Prelude Therapeutics Incorporated - Common Stock was at 11/05/25 04:00 PM ET
What is the market capitalization of Prelude Therapeutics Incorporated - Common Stock?
The market capitalization of Prelude Therapeutics Incorporated - Common Stock is 76.18M
How many shares of Prelude Therapeutics Incorporated - Common Stock are outstanding?
Prelude Therapeutics Incorporated - Common Stock has 76M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.